You are viewing: Brazil Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Brazil Long Read Sequencing Market was valued at $10.9 Million in 2024 and projected to reach to $41.5 Million by 2029, representing a compound annual growth rate of 30.6%. Brazil's long read sequencing market is poised for substantial growth through 2029, driven by increasing adoption of precision medicine approaches and genomic research initiatives.

Brazil Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Brazil Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 30.6%, reflecting Brazil's increasing adoption of advanced genomic technologies across research institutions, diagnostic laboratories, and clinical settings.
  • Brazil's investment in precision medicine and genomic infrastructure is driving demand for long read sequencing platforms that enable comprehensive DNA and RNA analysis. The Brazilian market benefits from growing healthcare expenditure, rising prevalence of genetic disorders, and expanding biopharmaceutical research activities.
  • Brazil's position as Latin America's largest economy supports the development of genomic capabilities and attracts international sequencing technology providers.
  • Between 2024 and 2029, Brazil is expected to consolidate its role as a regional leader in genomic innovation, with increased adoption among academic centers and private diagnostic providers seeking to enhance their sequencing capabilities..

Key Market Statistics

  • CAGR (2024-2029) 30.6% CAGR
  • Market Size, 2024 ~USD 10.9 Million
  • Forecast, 2029 ~USD 41.5 Million
  • Country Brazil

Brazil Long Read Sequencing Market Overview

Rapid Market Expansion :

Brazil's long read sequencing market is growing at 30.6% CAGR, nearly matching the global rate of 32.8%, demonstrating strong regional adoption and investment in genomic technologies.

Significant Revenue Growth :

Market valuation is projected to nearly quadruple from USD 10.9 million in 2024 to USD 41.5 million by 2029, indicating accelerating demand across research and clinical applications.

Precision Medicine Investment :

Brazil's commitment to precision medicine initiatives is driving adoption of long read sequencing in diagnostic laboratories and clinical settings, positioning the country as a regional leader.

Research Institution Growth :

Increasing investments by Brazilian research institutions and universities in advanced genomic technologies are creating substantial opportunities for long read sequencing platform deployment.

Brazil Long Read Sequencing Market Dynamics

  • The country's expanding healthcare infrastructure and growing investment in biotechnology research are creating favorable conditions for advanced sequencing technologies.
  • Research institutions and diagnostic laboratories are progressively integrating long read sequencing into their workflows, recognizing its advantages for complex genomic analysis and rare disease diagnosis.
  • Government support for precision medicine and biotechnology development further strengthens market fundamentals, positioning Brazil as a key growth market in Latin America..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Brazil's long read sequencing market is valued at USD 10.9 million in 2024 and is forecast to grow to USD 41.5 million by 2029, representing a 30.6% CAGR.
    • Brazil's expanding healthcare infrastructure and investment in precision medicine are primary drivers of long read sequencing adoption across diagnostic and research sectors.
    • Brazil's role as Latin America's largest economy positions it as a key market for genomic technology providers seeking regional expansion.
    • Brazil's growing biopharmaceutical research ecosystem and academic institutions are accelerating demand for advanced sequencing capabilities through 2029.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Brazil Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    BRAZIL: LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTE5.97.89.812.415.920.62736.730.3
    HOSPITALS, CLINICS, AND DIAGNOSTIC LABS1.72.32.93.74.86.38.311.331.2
    OTHER END USER0.60.80.91.11.41.72.22.925.8
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES2.83.74.65.97.59.812.817.430.3
    TOTAL11.114.618.22329.638.450.368.230.3

    Target Audience

    • Sequencing Technology Providers : Equipment manufacturers and platform developers need Brazil-specific market data to assess market potential, identify customer segments, and develop localized go-to-market strategies.
    • Diagnostic Laboratory Operators : Clinical and research laboratories require market insights to evaluate investment in long read sequencing capabilities and understand competitive positioning within Brazil's growing market.
    • Healthcare Investment Firms : Private equity and venture capital investors need Brazil market analysis to identify investment opportunities in genomics companies and assess regional growth potential.
    • Research Institution Leaders : University and research center administrators require market data to justify funding requests for sequencing infrastructure and align research capabilities with market demand.
    • Healthcare Policy & Strategy Teams : Government agencies and healthcare organizations need Brazil market intelligence to inform precision medicine policies, funding allocation, and technology adoption roadmaps.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Confirm Brazil's long read sequencing market valuation and validate the 30.6% CAGR projection through 2029 to support strategic investment and expansion decisions.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning specific to Brazil to identify partnership and market entry opportunities in this high-growth region.
    • Segment & Application Analysis : Access detailed breakdown of Brazil's market by application areas, end-users, and technology types to target the most lucrative segments and customer segments.
    • Regional Growth Drivers : Identify Brazil-specific factors driving adoption including precision medicine initiatives, research funding, and regulatory developments to inform go-to-market strategies.
    • Forecast-Driven Planning : Leverage 5-year market projections and growth trajectories for Brazil to develop accurate financial models, resource allocation, and long-term business planning.

    Frequently asked questions

    What is the current size of Brazil's long read sequencing market?

    Brazil's long read sequencing market was valued at USD 10.9 million in 2024 and is expected to grow significantly through the forecast period.

    What is the projected market size for Brazil's long read sequencing market by 2029?

    Brazil's long read sequencing market is projected to reach USD 41.5 million by 2029, driven by increased adoption of genomic technologies.

    What is the CAGR for Brazil's long read sequencing market?

    Brazil's long read sequencing market is expected to grow at a compound annual growth rate of 30.6% from 2024 to 2029.

    What factors are driving growth in Brazil's long read sequencing market?

    Growth in Brazil is driven by expanding healthcare infrastructure, rising investment in precision medicine, increasing prevalence of genetic disorders, and growing biopharmaceutical research activities.

    Which sectors in Brazil are adopting long read sequencing technology?

    Brazil's adoption spans academic research institutions, diagnostic laboratories, clinical settings, and biopharmaceutical companies seeking advanced genomic analysis capabilities.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status